Several studies investigated anti-EGFR IgA antibodies [9,10,43,59,65]; yet, studies of IgA antibodies with other tumor-targeting specificities remain scarce, and no evaluation of a panel of IgA antibodies with multiple targets using a human expression system is available. This evidence concerns the gene CD79A and neoplasm.